If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas. 

While there is no cure for multiple myeloma, a form of blood cancer, new therapy offers hope for keeping the disease from progressing. When used as a maintenance or ongoing therapy, Revlimid (lenalidomide) delays the progression of multiple myeloma and improves overall survival of newly diagnosed patients who have had a stem-cell transplant.

The majority of patients with chronic myeloid leukemia recover using various cancer drug treatments. However, they are not cured, as a type of cancerous stem cell is resistant to the drugs.

Researchers have gained new insights into one of the most aggressive tumors affecting humans, Burkitt's lymphoma cancer. There may be new ways of treating this painful and deadly disease with a new mechanism responsible for breaking down the genetic protections against tumors.

Researchers have discovered a new approach for treating slow-to-heal wounds such bed sores, chronic ulcers, and diabetic wounds.

A team of University of Wisconsin-Madison researchers has successfully completed the first reprogramming of blood cells obtained from a patient with leukemia.

Children vaccinated against hepatitis B might be at a lower risk of developing leukemia, according to a new study.

Follicular lymphoma patients fare better after receiving two years of rituximab-maintenance therapy following immunochemotherapy, according to a new study.

Researchers have found that screening newborns for severe combined immunodeficiency (SCID) substantially improves their survival.

New research has examined the crucial steps involved that turn brand new blood cells into immune cells or red blood cells, and how disruptions to this process can lead to blood diseases like leukemia.